FINAL PROGR AM - American Society of Gene & Cell Therapy

More documents

Recommendations

Info

AMERICAN SOCIETY OF GENE THERAPY • Final Program 151 EXHIBITOR DESCRIPTIONS Kemp Biotechnologies, Inc. 7307 Governors Way Frederick, MD 21704 Phone: 301-620-7100 Fax: 301-620-0162 E-Mail: b.miller@kempbiotech.com www.kempbiotech.com Booth Number: 407 Kemp Biotechnologies, Inc. will present a proprietary nontoxic transfection reagent and a proprietary transfection process, which enables AAV viral vector production via cotransfection of suspension 293 cells. This service is a scalable, cost-effective alternative to the time-consuming process of transfecting large quantities of plates of adherent 293 cell cultures to generate AAV vector stocks. Lark Technologies 9441 W. Sam Houston Parkway South, Suite 103 Houston, TX 77099 Phone: 713-779-3663 Fax: 713-779-1661 E-Mail: sales@lark.com www.lark.com Booth Number: 305 Lark, A Genaissance Company is a leading contract research organization providing research grade and regulatory submission services including DNA sequencing, quantitative PCR analysis, and genetic stability testing. All of Lark’s regulatory submission services comply with Good Laboratory Practices as specified by the FDA. Mary Ann Liebert, Inc. 2 Madison Ave. Larchmont, NY 10538 Phone: 914-834-3100 Fax: 914-834-3771 E-Mail: info@liebertpub.com www.liebertpub.com Booth Number: 112 Mary Ann Liebert, Inc. Publishers invites you to come by our booth #112, and take a complementary copy of Human Gene Therapy, Genetic Testing, Genetic Engineering News and other related publications. MDS Pharma Services 2350 Cohen Street Saint-Laurent (Montreal) Quebec, H4R 2N6 Canada Phone: 514-333-0033 Fax: 514-333-8861 E-Mail: info@mdsps.com www.mdsps.com Booth Number: 309 MDS Pharma Services’ biopharmaceuticals group executes rapid and rigorous GLP/cGMP safety and analytical testing. Our state-of-the-art facility in Bothell, Washington, features restricted-access laboratories and FDA and ICH compliance. Suites consist of BSL-2/BSL- 3 virology labs, cell culture and cell-banking (cGMP) facilities, protein chemistry and PCR rooms. For more information, visit www.mdsps.com. Mirus Bio Corporation 505 S. Rosa Road, Suite 104 Madison, WI 53705 Phone: 608-441-2824 Fax: 608-441-2849 E-Mail: Claire.ruzicka@mirusbio.org www.mirusbio.com Booth Number: 505 Mirus Bio provides state-of-the-art nucleic acid delivery and labeling reagents for in vitro and in vivo research. TransIT â reagents achieve high efficiency/low toxicity transfections in a variety of cell lines and applications including siRNA delivery. Label IT â non-enzymatic nucleic acid labeling kits are optimized for hybridization and tracking applications. Molecular Medicine Bioservices, Inc. 6219 el Camino Real Carlsbad, CA 92009 Phone: 760-918-0007 Fax: 760-918-0076 E-Mail: dbacker@molecularmed.com www.molecularmed.com Booth Number: 315 Molecular Medicine BioServices, Inc. provides enabling technologies for viral-based therapeutics. Located in Carlsbad, CA, the company is a leading contract manufacturing and clinical production resource for companies engaged in vaccine and gene therapy development. Molecular Medicine is committed to supporting clients from development through production and into clinical approval.
152 8th Annual Meeting • June 1 - 5, 2005 • St. Louis EXHIBITOR DESCRIPTIONS National Gene Vector Laboratories 650 Barnhill Drive, MS 205 Indianapolis, IN 46202-5120 Phone: 317-274-0448 Fax: 317-274-4518 E-Mail: kwicker@iupui.edu www.ngvl.org Booth Number: 215 The NGVL consist of three vector production facilities located at Indiana University, Baylor College of Medicine, and the City of Hope/Beckman Research Institute. Two pharmacology/toxicology centers have been established at the University of Florida and Southern Research Institute. The production sites will generate clinical grade adenoviral, adeno-associated virus, DNA plasmid, lentivirus, herpes simplex virus and retrovirus vectors for Phase I/II gene therapy protocols, while the pharmacology/toxicology centers will provide support for investigators needing such studies for their clinical protocols. Requests for vector production and/or pharmacology/ toxicology support will be reviewed by the Scientific Review Board and Steering Committee of the NGVL with selection based upon scientific merit, feasibility and availability of NGVL resources. If the application is approved through the Steering Committee, clinical grade materials and pharmacology/toxicology studies will be provided without charge for human gene therapy trials. An application packet can be downloaded from the NGVL website at http://www.ngvl.org or obtained through the Coordinating Center. Nature Publishing Group 345 Park Avenue New York, NY 10010 Phone: 212-726-9200 E-Mail: institutions@natureny.com www.nature.com Booth Number: 108 Nature Publishing Group publishes quality research and review material; timely news; and essential career and recruitment information in science and clinical medicine. NPG combines the excellence of Nature, its associated primary research journals, the new Nature Clinical Practice review series, Nature Methods plus over 30 leading international scientific, clinical, and medical journals. Nature Technology Corporation 4701 Innovation Drive Lincoln, NE 68521 Phone: 402-472-6530 Fax: 402-472-6532 E-Mail: natx@natx.com www.natx.com Booth Number: 604 Nature Technology Corporation (NTC) is a full-service vector development company, specializing in the production of plasmid DNA and recombinant proteins for research and preclinical use. NTC’s pDNA fermentation process currently produces DNA at >1g/L, leading the industry in quality and economy: http://www.natx.com. Office of Biotechnology Activities, National Institutes of Health 6705 Rockledge Drive, Suite 750 Bethesda, MD 20892 Phone: 301-496-9838 Fax: 301-496-9839 E-Mail: bm128w@nih.gov www4.od.nih.gov/oba Booth Number: 205-207 The NIH Office of Biotechnology Activities (OBA) will be exhibiting its initiatives, and staff will be available to answer questions about the oversight of recombinant DNA research, including human gene transfer research. Meeting participants will be given “hands-on” demonstrations of OBA’s Genetic Modification Clinical Research Information System (GeMCRIS), as well as an extensive, Web-based resource on informed consent in gene transfer research. Olympus America Inc. Two Corporate Center Drive Melville, NY 11747 Phone: 631-844-5051 Fax: 631-844-5112 E-Mail: Catherine.coll@olympus.com www.olympusamerica.com Booth Number: 211 Olympus will feature the IX81 inverted motorized research microscope along with our innovative spinning disk confocal technology. When combined with our latest digital camera and SlideBook imaging software, Olympus can help you customize a complete system suited for your application needs and budget.
Page 1 and 2:
AMERICAN SOCIETY OF GENE THERAPY 8t
Page 3 and 4:
2 8th Annual Meeting • June 1 - 5
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
10 8th Annual Meeting • June 1 -
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102: 100 8th Annual Meeting • June 1 -
Page 151: 150 8th Annual Meeting • June 1 -
Page 157 and 158: 156 NOTES 8th Annual Meeting • Ju
show all

FINAL PROGR AM - American Society of Gene & Cell Therapy

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?